To address the possible mechanism of chemoresistance mediated by RHAMM, we examined the expression of CD44, another receptor of HA and representative marker of breast cancer stem cells (CSCs) [35], because CSCs are closely associated with chemoresistance of human malignancies, including breast cancer [36,37]. This evidence concerns the gene CD44 and breast carcinoma.